AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan BuyoutThe Motley Fool • 07/21/19
Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019Investors Business Daily • 07/10/19